Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers.

Oxidative stress is believed to play an important role in the pathogenesis of smoking-induced chronic obstructive pulmonary disease. We hypothesized that polymorphisms of antioxidant genes glutathione S-transferase M1 (GSTM1), GSTT1, GSTP1, and heme oxygenase-1 (HMOX1) would be associated with susceptibility to accelerated decline of lung function in smokers. We genotyped 621 subjects (299 rapid decliners [change in forced expiratory volume in 1 second (DeltaFEV(1)) = -152 +/- 2.5 ml/year] and 322 nondecliners [DeltaFEV(1) = +15 +/- 1.5 ml/year]) selected from among smokers followed for 5 years in the National Heart, Lung, and Blood Institute Lung Health Study. Because genotype frequencies were different between ethnic groups, we limited the association study to 594 whites (286 rapid decliners and 308 nondecliners). None of the genotypes studied had a statistically significant effect on decline of lung function when analyzed separately. There was an association between rapid decline of lung function and presence of all three GST polymorphisms (odds ratio [OR] = 2.83; p = 0.03). A combination of a family history of chronic obstructive pulmonary disease with GSTP1 105Ile/Ile genotype was also associated with rapid decline of lung function (OR = 2.20; p = 0.01). However, due to the multiple comparisons that were made, these associations may represent type 1 error. There was no association between HMOX1 (GT)n alleles and the rate of decline in lung function in smokers.

[1]  F. Ali-Osman,et al.  Genetic polymorphism at the glutathione S‐tranferase (GST) P1 locus is a breast cancer risk modifier , 2001, International journal of cancer.

[2]  N. Anthonisen,et al.  Susceptibility genes for rapid decline of lung function in the lung health study. , 2001, American journal of respiratory and critical care medicine.

[3]  A. Spurdle,et al.  Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype. , 2001, Carcinogenesis.

[4]  P. Barnes,et al.  Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.

[5]  P. Donnelly,et al.  Association mapping in structured populations. , 2000, American journal of human genetics.

[6]  K. Roeder,et al.  The power of genomic control. , 2000, American journal of human genetics.

[7]  W. Tan,et al.  Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  W. MacNee,et al.  Oxidants/antioxidants and COPD. , 2000, Chest.

[9]  S. Namkoong,et al.  Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1a1, and CYP2e1 , 2000, Cancer.

[10]  S. Schwartz,et al.  Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  C. Rochester,et al.  Smoking and chronic obstructive pulmonary disease. , 2000, Clinics in chest medicine.

[12]  J. Yim,et al.  Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1 , 2000, Thorax.

[13]  S. Shibahara,et al.  Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. , 2000, American journal of human genetics.

[14]  Y. Ouchi,et al.  Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease , 1999, Thorax.

[15]  T. Wobbes,et al.  Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma. , 1999, Cancer research.

[16]  S. Anttila,et al.  Combined effect of polymorphic GST genes on individual susceptibility to lung cancer , 1998, International journal of cancer.

[17]  B Rosner,et al.  Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. , 1998, American journal of respiratory and critical care medicine.

[18]  G. B. Smith,et al.  Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. , 1998, Carcinogenesis.

[19]  A. Sandford,et al.  Genetic risk factors for chronic obstructive pulmonary disease , 2000, The European respiratory journal.

[20]  A Bast,et al.  Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. , 1997, American journal of respiratory and critical care medicine.

[21]  D. Lamb,et al.  Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer , 1997, Human & experimental toxicology.

[22]  V. Baranov,et al.  Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis , 1997, Human Genetics.

[23]  J. Buolamwini,et al.  Molecular Cloning, Characterization, and Expression in Escherichia coli of Full-length cDNAs of Three Human Glutathione S-Transferase Pi Gene Variants , 1997, The Journal of Biological Chemistry.

[24]  D. Forman,et al.  Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. , 1997, Carcinogenesis.

[25]  M. Maines,et al.  The heme oxygenase system: a regulator of second messenger gases. , 1997, Annual review of pharmacology and toxicology.

[26]  K. Takahashi,et al.  Regulation of human heme oxygenase-1 gene expression under thermal stress. , 1996, Blood.

[27]  W. MacNee,et al.  Role of oxidants/antioxidants in smoking-induced lung diseases. , 1996, Free radical biology & medicine.

[28]  S. Weiss,et al.  A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary-function decline: the Normative Aging Study. , 1995, American journal of respiratory and critical care medicine.

[29]  J. Hayes,et al.  Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. , 1995, Free radical research.

[30]  W. Bailey,et al.  Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .

[31]  H. Bolt,et al.  Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. , 1994, The Biochemical journal.

[32]  S. Shibahara,et al.  Structural organization of the human heme oxygenase gene and the function of its promoter. , 1989, European journal of biochemistry.

[33]  R. Pero,et al.  A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. , 1986, Carcinogenesis.

[34]  B. Mannervik.  The isoenzymes of glutathione transferase. , 2006, Advances in enzymology and related areas of molecular biology.

[35]  R M Gardner,et al.  Reference spirometric values using techniques and equipment that meet ATS recommendations. , 2015, The American review of respiratory disease.

[36]  R. Madison,et al.  Inherited risk factors for chronic lung disease. , 1980, Chest.

[37]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.